recent
year
coagulaseneg
strain
staphylococcu
epidermidi
becom
frequent
caus
infect
connect
surgic
implant
medic
devic
parallel
appear
multiresist
vancomycinresist
epidermidi
strain
increas
quickli
due
increas
use
antibiot
hospit
primari
pathogen
trait
epidermidi
associ
abil
form
biofilm
surfac
medic
devic
limit
sever
efficaci
mani
convent
antibiot
biofilm
may
also
protect
bacteria
attack
host
defenc
system
also
observ
aminoglycosid
antibiot
may
trigger
biofilm
format
bacteria
therefor
urgent
need
design
novel
antibiot
staphylococcu
infect
especi
relat
biofilm
develop
recent
complet
genom
sequenc
two
epidermidi
strain
viz
nonbiofilmform
strain
biofilmform
strain
publish
bring
new
opportun
discov
potenti
antimicrobi
target
use
silico
genom
analys
twocompon
system
tc
control
protein
harbor
histidin
kinas
hk
respons
transcript
regul
activ
uncov
bacteria
recent
tcss
attract
attent
due
potenti
novel
antibacteri
target
especi
requir
regul
bacteri
growth
virul
pathogen
microorgan
one
tc
yycgyycf
highli
conserv
specif
low
gc
gramposit
bacteria
shown
essenti
bacillu
subtili
staphylococcu
aureu
surviv
inhibitor
yycg
hk
synthet
imidazol
zerumbon
deriv
aranorosinol
b
obtain
screen
aceton
extract
microb
document
effect
antibacteri
agent
b
subtili
identif
limit
number
yycg
inhibitor
requir
labori
biolog
chemic
experi
sideeffect
compound
mammalian
cell
remain
unclear
moreov
b
subtili
may
optim
model
organ
investig
biofilm
format
process
major
import
virul
staphylococci
prompt
us
demonstr
epidermidi
possess
homolog
yycgyycf
tc
investig
whether
would
appropri
target
design
novel
antibacteri
agent
prerequisit
set
rapid
conveni
procedur
screen
novel
inhibitor
yycgyycf
tc
test
possibl
effect
inhibitor
plankton
sessil
bacteria
use
extrem
sensit
mammalian
cell
control
put
asid
compound
would
display
nonspecif
effect
membran
upon
bind
mani
small
molecul
may
affect
function
protein
function
analysi
basi
varieti
experi
synthet
purifi
small
molecul
use
probe
molecular
mechan
underli
biolog
process
target
protein
involv
chemistrybas
approach
coin
chemic
biolog
combinatori
chemistri
vivo
vitro
high
throughput
screen
ht
constitut
prefer
approach
discov
activ
compound
particular
protein
target
complementari
approach
use
comput
method
identifi
activ
compound
binder
hit
target
threedimension
structur
substrat
bind
pocket
protein
silico
approach
call
structurebas
virtual
screen
sbv
present
studi
first
identifi
homolog
yycgyycf
tc
genom
epidermidi
strain
next
structur
model
conserv
hatpasec
domain
epidermidi
yycg
hk
construct
use
homolog
model
approach
subsequ
sbv
method
use
search
potenti
yycg
inhibitor
spec
chemic
leadcompound
databas
candid
select
databas
sbv
seven
compound
activ
inhibit
growth
epidermidi
plate
liquid
media
five
compound
display
bactericid
effect
plankton
biofilm
cell
epidermidi
except
one
compound
bound
yycg
protein
inhibit
autophosphoryl
vitro
compound
display
low
cytotox
mammalian
cell
hemolyt
indic
may
good
lead
develop
new
antibiot
staphylococci
infect
base
sequenc
homolog
identifi
like
counterpart
yycgyycf
tc
genbank
access
number
genom
epidermidi
sequenc
yycg
protein
epidermidi
highli
homolog
aureu
b
subtili
ident
respect
true
yycf
protein
ident
respect
yycg
yycf
persist
protein
firmicut
confid
function
preserv
clade
importantli
attempt
inactiv
ortholog
yycgyycf
gene
identifi
epidermidi
work
also
fail
homolog
recombin
technolog
indic
tc
requir
bacteri
growth
epidermidi
data
shown
domain
analysi
indic
yycg
protein
epidermidi
contain
one
transmembran
segment
sever
domain
identifi
protein
hamp
domain
present
histidin
kinas
adenylyl
cyclas
methylaccept
protein
phosphatas
pa
domain
initi
found
common
period
circadian
protein
ah
receptor
nuclear
transloc
protein
singlemind
protein
hiska
hatpasec
common
bacteri
hk
moreov
yycf
protein
epidermidi
possess
conserv
rec
domain
contain
phosphoacceptor
site
may
phosphoryl
yycg
transregc
domain
belong
omprlik
wing
helixturnhelix
dnabind
domain
figur
interestingli
multialign
hatpasec
domain
sequenc
counterpart
bacteria
structur
protein
data
bank
pdb
show
sequenc
around
atp
bind
site
bacteria
similar
show
four
conserv
import
motif
n
box
box
f
box
box
demonstr
atp
bind
domain
hk
highli
conserv
bacteria
suggest
may
use
potenti
target
antibacteri
agent
screen
comparison
yycg
hatpasec
domain
epidermidi
similar
domain
databas
show
homolog
sequenc
similar
domain
e
coli
osmosensor
envz
tc
molecul
sequenc
ident
conserv
replac
figur
envz
therefor
use
templat
model
structur
yycg
hatpasec
domain
epidermidi
search
potenti
inhibitor
yycg
hk
virtual
screen
construct
model
yycg
hatpasec
domain
epidermidi
base
nmr
structur
homolog
domain
e
coli
osmosensor
envz
pdb
entri
result
model
structur
shown
figur
final
structur
check
valid
use
sever
program
prostat
model
superpos
well
nmr
structur
homolog
domain
envz
rootmeansquar
deviat
rmsd
atom
figur
hatpasec
domain
yycg
thu
predict
fold
similar
way
envz
contain
five
strand
four
form
twolay
sandwich
structur
figur
surfac
shape
gener
featur
hatpasec
domain
yycg
investig
use
molcad
modul
sybyl
atp
bind
site
consist
two
differ
caviti
connect
gorgelik
channel
figur
structur
predict
use
virtual
drug
screen
bear
mind
experiment
evid
would
valid
model
atpbind
pocket
form
residu
within
radiu
around
atp
site
yycg
hatpasec
model
epidermidi
use
target
site
high
throughput
virtual
screen
htv
first
step
potenti
druglik
molecul
constitut
inhous
databas
name
select
spec
databas
use
drugselect
filter
develop
zheng
et
al
databas
search
potenti
bind
molecul
structur
use
program
primari
screen
optim
structur
subsequ
rescor
use
flexx
program
cscore
consensu
score
method
integr
five
popular
score
function
two
hundr
molecul
pass
highli
select
filter
final
molecul
manual
select
latter
sampl
inhibitor
candid
accord
molecular
divers
shape
complementar
potenti
form
hydrogen
bond
bind
pocket
yycg
hatpasec
domain
candid
compound
sampl
could
purchas
spec
compani
experiment
assay
sinc
yycgyycf
tc
essenti
growth
surviv
b
subtili
aureu
conserv
sequenc
genom
organ
epidermidi
strongli
suggest
essenti
organ
well
test
possibl
explor
whether
potenti
yycg
inhibitor
candid
obtain
virtual
screen
could
inhibit
bacteri
growth
concentr
liquid
cultur
first
screen
procedur
seven
candid
complet
inhibit
growth
epidermidi
seven
inhibitor
belong
four
differ
class
chemic
structur
three
thiazolidinon
analog
compound
two
benzamid
analog
compound
one
furan
deriv
compound
one
deriv
pyrimidinon
compound
shown
figur
subsequ
minim
inhibitori
concentr
mic
valu
compound
determin
use
standard
tubedilut
assay
tabl
compound
shown
similar
mic
valu
test
clinic
isol
epidermidi
differ
patient
zhongshan
hospit
shanghai
china
data
shown
compound
show
similar
mic
valu
see
tabl
epidermidi
nonbiofilmform
strain
biofilmform
strain
wherea
compound
effect
nonbiofilmform
strain
also
investig
inhibitori
effect
gramposit
pathogen
cocci
possess
homolog
yycgyycf
tc
experi
show
compound
effect
aureu
streptococcu
pyogen
streptococcu
mutan
compound
inhibit
growth
aureu
pyogen
compound
activ
pyogen
contrast
none
compound
activ
gramneg
bacteria
escherichia
coli
pseudomona
aeruginosa
concentr
consist
absenc
yycgyycf
tc
counterpart
genom
taken
togeth
first
observ
suggest
compound
like
act
trivial
interact
membran
structur
subsequ
investig
bactericid
activ
compound
epidermidi
use
standard
minim
bactericid
concentr
mbc
assay
five
compound
mbc
valu
time
mic
threshold
obviou
differ
observ
biofilmform
strain
nonbiofilmform
strain
epidermidi
tabl
standard
micmbc
assay
measur
antimicrobi
activ
plankton
bacteria
wherea
antibiot
resist
report
enhanc
cell
develop
biofilm
therefor
measur
bactericid
effect
compound
sessil
cell
epidermidi
vancomycin
one
antibiot
usual
use
multidrugresist
staphylococci
associ
infect
comparison
mbcmic
epidermidi
strain
compar
vancomycin
potenti
yycg
inhibitor
compound
show
better
kill
effici
biofilm
cell
epidermidi
mbc
valu
respect
figur
best
chemic
compound
reduc
cfu
biofilm
cell
rel
untreat
control
contrast
vancomycin
caus
increas
kill
biofilm
cell
even
concentr
increas
rel
mbc
valu
data
shown
addit
recent
data
use
confoc
laser
scan
microscop
clsm
also
confirm
compound
exhibit
much
better
kill
effect
vancomycin
cell
embed
matur
biofilm
epidermidi
clinic
isol
data
shown
vivo
effect
inhibitor
extract
silico
screen
procedur
consist
yycg
target
howev
straightforward
extrapol
silico
design
accur
identif
target
vivo
order
confirm
interact
potenti
yycg
inhibitor
put
target
protein
recombin
histag
yycg
protein
fragment
yycg
protein
use
silico
approach
approxim
kda
indic
method
overproduc
use
plasmid
purifi
use
purif
system
see
addit
file
protein
puriti
bind
affin
seven
put
yycg
inhibitor
yycg
protein
determin
use
surfac
plasmon
reson
spr
vitro
six
compound
display
high
bind
affin
yycg
protein
tabl
wherea
compound
bound
poorli
yycg
protein
posit
compound
display
signific
dosedepend
bind
pattern
spr
respons
five
compound
show
characterist
squarewav
bind
curv
indic
compound
form
unstabl
complex
yycg
protein
process
fast
associ
fast
dissoci
compound
shown
figur
compound
display
slow
associ
slow
dissoci
reaction
form
rel
stabl
complex
yycg
protein
figur
data
fit
steadyst
affin
model
compound
kineticst
model
compound
use
biacor
softwar
evalu
correspond
bind
affin
kd
valu
shown
tabl
kd
valu
compound
calcul
poor
bind
affin
yycg
protein
common
characterist
hk
atpdepend
autophosphoryl
associ
conserv
hatpasec
domain
measur
effect
potenti
yycg
inhibitor
protein
atpas
activ
use
luminesc
kinas
assay
firstli
put
kinas
activ
yycg
protein
measur
quantifi
amount
atp
remain
solut
reaction
direct
relationship
exist
luminesc
measur
reagent
amount
atp
see
addit
file
indic
sensit
assay
good
ad
purifi
yycg
protein
reaction
system
protein
reaction
system
luminesc
decreas
group
contain
differ
atp
concentr
compar
parallel
group
without
yycg
treatment
see
addit
file
sinc
kinas
hydrolyz
atp
autophosphoryl
keep
atp
concentr
constant
luminesc
continu
decreas
follow
amount
purifi
yycg
protein
increas
see
addit
file
result
indic
purifi
yycg
protein
possess
atpas
activ
vitro
concentr
compound
decreas
atpas
activ
yycg
protein
presenc
atp
respect
indic
bind
affin
compound
yycg
correl
well
inhibitori
activ
autophosphoryl
yycg
contrast
compound
bind
poorli
yycg
protein
show
almost
activ
yycg
atpas
activ
approxim
inhibit
concentr
need
decreas
yycg
atpas
activ
valu
activ
compound
calcul
gradual
dilut
compound
invari
concentr
protein
atp
shown
tabl
valu
compound
reaction
condit
comparison
fragment
anoth
hk
protein
srrb
contain
homolog
domain
yycg
epidermidi
also
express
purifi
observ
inhibitori
effect
protein
phosphotyl
potenti
yycg
inhibitor
suppl
tabl
concentr
compound
display
much
lower
inhibitori
effect
srrb
yycg
compound
almost
inhibitori
effect
sever
compound
identifi
could
use
excel
drug
lead
act
target
absent
eukaryot
cell
still
may
display
toxic
interf
unexpect
target
step
rule
possibl
analyz
cytotox
compound
vero
cell
line
vero
african
greenmonkey
use
tradit
tetrazolium
bromid
mtt
method
cell
prolifer
kit
roch
see
method
approach
would
also
provid
us
sensit
assay
draw
asid
trivial
action
product
membran
lipid
bilay
remark
shown
tabl
valu
higher
highest
inhibitor
concentr
use
except
case
two
inhibitor
compound
valu
concentr
induc
cytotox
effect
vero
cell
furthermor
concentr
respect
mic
valu
compound
display
low
almost
cytotox
data
shown
report
tc
inhibitor
induc
hemolysi
mammalian
erythrocyt
hinder
develop
applic
inhibitor
prompt
us
analyz
possibl
membran
damag
caus
potenti
yycg
inhibitor
examin
hemolysi
healthi
human
erythrocyt
possibl
induc
compound
mic
concentr
compound
display
appar
hemolysi
zero
control
compar
well
effect
convent
antibiot
tetracyclin
ciprofloxacin
tabl
figur
time
mic
concentr
compound
show
littl
hemolysi
zero
control
highest
concentr
hemolyt
activ
compound
increas
zero
control
potenti
yycg
inhibitor
six
compound
select
silico
screen
bound
high
affin
yycg
protein
inhibit
atpas
activ
vitro
investig
site
interact
compound
yycg
protein
develop
strategi
design
novel
inhibitor
model
interact
compound
yycg
protein
analyz
base
dock
simul
surfac
yycg
hatpasec
domain
show
two
signific
hydrophob
area
locat
atpbind
pocket
one
place
inner
small
caviti
compos
residu
posit
front
outer
larger
caviti
consist
residu
figur
residu
conserv
bacteri
hk
bind
conform
inhibitor
design
present
studi
atpbind
pocket
yycg
hatpasec
domain
shown
figur
although
structur
divers
adopt
similar
interact
conserv
domain
accord
interact
model
fourpoint
pharmacophor
figur
describ
bind
inhibitor
figur
middl
part
inhibitor
two
hydrogen
bond
acceptor
hydrogen
bond
stabil
one
six
inhibitor
candid
bind
pocket
hydrophob
moieti
inhibitor
fit
well
two
hydrophob
caviti
notic
bind
model
reveal
prime
import
stabil
interact
inhibitor
yycg
protein
well
agreement
previou
biolog
function
studi
demonstr
conserv
n
box
necessari
ligand
bind
class
ii
tc
contrast
residu
specif
yycg
bind
model
provid
new
possibl
studi
biolog
function
ligand
bind
catalysi
yycg
figur
besid
interact
hydrophob
area
mainli
construct
residu
may
bind
hydrophob
part
differ
compound
stabil
inner
hollow
pocket
residu
conserv
homolog
hk
data
shown
yycgyycf
tc
conserv
specif
low
gc
gramposit
bacteria
b
subtili
aureu
streptococcu
pneumonia
listeria
monocytogen
tc
shown
essenti
b
subtili
could
inactiv
direct
mutat
aureu
also
occur
epidermidi
work
moreov
sever
gene
involv
cellwal
biosynthesi
metabol
teichoic
acid
biosynthesi
protein
f
cell
wall
synthesi
protein
ypfp
predict
regul
tc
epidermidi
base
presenc
potenti
yycf
consensu
dna
bind
recognit
sequenc
similar
one
describ
b
subtili
aureu
although
predict
result
need
verifi
qin
et
al
unpublish
data
therefor
explor
possibl
use
yycg
hk
potenti
target
screen
new
antibiot
compar
biolog
chemic
screen
new
antibiot
advantag
sbv
technolog
rapid
econom
effici
throughput
furthermor
leadcompound
databas
provid
ampl
sourc
screen
wherea
chemic
synthesi
time
consum
expens
case
point
use
leadcompound
databas
alreadi
led
discoveri
diarylquinolin
leadcompound
mycobacterium
tuberculosi
screen
possibl
compound
silico
final
retain
among
promis
candid
potenti
yycg
hk
inhibitor
compound
bound
yycg
protein
vitro
inhibit
atpas
activ
also
activ
antimicrobi
epidermidi
prove
howev
yycg
target
compound
interact
bacteria
fact
found
total
put
tcss
genom
epidermidi
includ
yycgyycf
mani
core
featur
common
exclud
compound
may
also
bind
hk
would
fact
enhanc
antibiot
effect
compound
investig
possibl
express
purifi
fragment
anoth
hk
epidermidi
srrb
design
srrb
contain
similar
domain
yycg
describ
method
involv
tc
srrbsrra
analyz
effect
activ
compound
autophosphoryl
purifi
protein
observ
compound
inhibit
autophosphoryl
srrb
inhibit
approxim
lower
demonstr
yycg
reaction
condit
see
addit
file
suggest
compound
display
certain
degre
specif
depend
characterist
hatpasec
domain
structur
differ
hk
one
interest
challeng
goal
new
search
antimicrobi
compound
identifi
potenti
drug
equal
activ
plankton
sessil
bacteria
biofilm
yycg
inhibitor
compound
describ
found
somewhat
reduc
bactericid
effect
matur
biofilm
epidermidi
compound
howev
much
effici
sessil
bacteria
commonli
use
staphylococcu
antibiot
vancomycin
fact
vancomycin
almost
without
effect
biofilm
cell
even
also
report
other
account
aureu
reduc
penetr
vancomycin
delay
exposur
bacteria
biofilm
deeper
layer
howev
remain
unknown
whether
situat
compound
epidermidi
biofilm
interestingli
seventeen
compound
among
candid
retain
studi
activ
inhibit
biofilm
format
without
interf
bacteri
growth
bind
yycg
protein
inhibit
autophosphoryl
vitro
indic
compound
potenti
inhibitor
yycg
hk
data
shown
target
epidermidi
mechan
inhibit
biofilm
format
still
investig
previou
studi
potenti
inhibitor
histidin
kinas
appear
display
trivial
side
effect
membran
disrupt
excess
protein
bind
limit
bioavail
prevent
develop
studi
potenti
yycg
inhibitor
display
low
cytotox
low
hemolysi
mammalian
cell
effect
concentr
use
vitro
process
find
effect
deriv
use
lead
futur
work
appropri
anim
model
also
need
establish
investig
effect
compound
vivo
tc
twocompon
system
hk
histidin
kinas
sbv
structurebas
virtual
screen
ht
high
throughput
screen
mic
minim
inhibitori
concentr
threedimension
spr
surfac
plasmon
reson
staphylococcu
epidermidi
strain
purchas
american
type
cultur
collect
atcc
manassa
usa
staphylococcu
aureu
escherichia
coli
pseudomona
aeruginosa
kindli
provid
dr
biji
hu
zhongshan
hospit
shanghai
china
epidermidi
strain
streptococcu
pyogen
strain
streptococcu
mutan
strain
clinic
isol
zhongshan
hospit
huashan
hospit
shanghai
china
state
otherwis
epidermidi
aureu
strain
grown
tryptic
soy
broth
tsb
oxoid
contain
glucos
e
coli
p
aeruginosa
strain
grown
luriabertani
lb
oxoid
compound
use
inhibitor
candid
purchas
spec
compani
netherland
stock
solut
compound
prepar
dimethyl
sulfoxid
dmso
chemic
reagent
grade
ultrapur
qualiti
purchas
sigma
domain
analysi
perform
base
smart
databas
complet
genom
sequenc
two
epidermidi
strain
access
nation
center
biotechnolog
inform
ncbi
genom
databas
homolog
sequenc
yycg
hatpasec
domain
epidermidi
search
protein
data
bank
pdb
use
blastp
program
clustalx
use
align
protein
sequenc
sequenc
epidermidi
hk
yycg
retriev
genbank
access
number
modul
encod
insightii
use
pairwis
sequenc
align
use
secondari
structur
inform
envz
pdb
entri
sequenc
align
adjust
manual
obtain
fine
align
structur
construct
model
yycg
hatpasec
domain
gener
use
model
program
encod
insightii
final
whole
structur
model
optim
use
modul
insightii
cvff
forc
field
sever
structur
analysi
softwar
prostat
use
check
structur
qualiti
prostat
modul
insightii
use
analyz
properti
bond
angl
torsion
program
use
check
structur
sequenc
compat
dock
small
molecul
interest
model
structur
delin
gener
featur
bind
pocket
major
residu
possibl
compos
atpbind
site
yycg
hatpasec
domain
identifi
sequenc
align
osmolar
sensor
protein
envz
e
coli
atpbind
pocket
probe
optim
model
yycg
hatpasec
domain
use
siteid
program
encod
surfac
electrostat
hydrophob
hydrogen
bond
properti
bind
pocket
yycg
hatpasec
domain
calcul
use
molcad
program
encod
atpbind
pocket
yycg
hatpasec
domain
use
target
screen
spec
databas
use
dock
approach
spec
databas
contain
structur
inform
small
molecul
spec
compani
suppli
compound
sampl
collect
differ
sourc
first
step
spec
databas
submit
filter
drugabl
nondrug
molecul
elimin
databas
final
potenti
drugabl
molecul
select
dock
screen
program
dock
use
primari
screen
residu
within
radiu
around
atpbind
pocket
yycg
hatpasec
domain
use
construct
grid
dock
screen
dock
calcul
kollmanallatom
charg
assign
protein
charg
assign
small
molecul
conform
flexibl
compound
databas
implement
dock
search
dock
simul
ligandreceptor
bind
energi
approxim
sum
van
der
waal
electrostat
interact
energi
initi
evalu
orient
score
gridbas
minim
carri
ligand
locat
nearest
local
energi
minimum
within
receptor
bind
site
posit
conform
dock
molecul
optim
use
singl
anchor
search
torsion
minim
method
dock
compound
highest
score
obtain
dock
search
select
second
round
dock
use
flexx
program
cscore
use
rescor
compound
virtual
screen
perform
supercomput
shanghai
supercomput
center
mic
assay
antibacteri
activ
compound
perform
accord
broth
microdilut
tube
method
clinic
laboratori
standard
institut
clsi
america
minim
bactericid
concentr
mbc
obtain
subcultur
neg
visibl
bacteri
growth
tube
mic
assay
onto
substancefre
muellerhinton
agar
plate
plate
incub
hour
mbc
defin
lowest
concentr
substanc
produc
subcultur
grow
five
coloni
plate
overnight
cultur
epidermidi
strain
dilut
tsb
contain
glucos
ml
bacteri
suspens
inocul
well
steril
polystyren
microtit
plate
falcon
incub
h
plate
matur
biofilm
wash
gentli
four
time
steril
pb
ad
fresh
tsb
contain
variou
compound
mbc
valu
incub
h
plate
wash
four
time
steril
pb
biofilm
cell
scrape
plate
resuspend
ml
pb
violent
vortex
disintegr
clump
cell
next
suspens
dilut
gradual
steril
pb
subcultur
onto
substancefre
muellerhinton
agar
plate
incub
h
coloni
count
fresh
medium
contain
vancomycin
mbc
valu
substancefre
fresh
medium
serv
control
experi
repeat
three
time
yycg
fragment
contain
cytoplasm
signal
domain
hatpasec
hiska
domain
see
figur
yycg
amplifi
pcr
chromosom
dna
epidermidi
templat
gcggatccacaacaacaagtcgaacgtgaac
gcctcgagttattcatcccaatcaccgtct
primer
subsequ
fragment
digest
bamhi
xholi
takara
japan
ligat
correspond
site
promega
madison
usa
obtain
petyycg
express
yycg
protein
purifi
purif
system
invitrogen
california
usa
accord
manufactur
protocol
vitro
bind
affin
inhibitor
compound
yycg
protein
determin
use
surfac
plasmon
reson
spr
biosensor
technolog
dual
flow
cell
biacor
instrument
biacor
ab
uppsala
sweden
similar
method
describ
previou
studi
immobil
yycg
protein
hydrophil
carboxymethyl
dextran
matrix
sensor
chip
biacor
carri
standard
primari
amin
coupl
reaction
protein
coval
bound
matrix
dilut
mm
sodium
acet
buffer
ph
final
concentr
mgml
equilibr
baselin
complet
continu
flow
hbsep
run
buffer
mm
hepe
mm
nacl
mm
edta
vv
surfact
ph
chip
hour
biacor
data
collect
hbsep
run
buffer
constant
flow
mlmin
sensorgram
process
use
automat
correct
nonspecif
bulk
refract
index
effect
equilibrium
constant
kd
evalu
proteinligand
bind
affin
determin
steadi
state
kinet
state
affin
fit
model
encod
biacor
analysi
softwar
inhibitori
activ
compound
atpas
activ
yycg
protein
measur
use
luminesc
kinas
assay
promega
madison
usa
briefli
yycg
protein
preincub
seri
dilut
compound
reaction
buffer
mm
tri
ph
mm
mgml
bsa
min
atp
ad
anoth
incub
min
reagent
ad
detect
rest
amount
atp
record
luminesc
measur
rlu
parallel
theyycg
protein
addit
compound
use
control
rate
inhibit
protein
phosphoryl
rp
compound
calcul
equat
r
p
rlu
yyc
g
compound
atp
reagent
rlu
yyc
g
atp
reagent
rlu
atp
reagent
rlu
yyc
g
atp
reagent
mathtyp
mtef
concentr
inhibit
yycg
protein
autophosphoryl
obtain
use
origin
softwar
originlab
northampton
usa
cytotox
antibacteri
compound
cultur
vero
cell
measur
use
cell
prolifer
kit
mtt
roch
indianapoli
usa
accord
manufactur
protocol
addit
dmso
medium
produc
slight
cytotox
vero
cell
could
easili
correct
assay
perform
quadrupl
repeat
three
time
result
convert
percentag
control
cell
treat
dmso
concentr
produc
cytotox
effect
vero
cell
calcul
origin
softwar
originlab
northampton
usa
hemolyt
activ
compound
determin
use
healthi
human
erythrocyt
erythrocyt
wash
three
time
steril
salin
resuspend
prior
assay
volum
cell
suspens
contain
mic
concentr
compound
ad
quadrupl
well
microtit
plate
falcon
cell
without
compound
treatment
cell
treatment
use
hemolysi
control
respect
cell
suspens
incub
hour
centrifug
min
volum
supernat
transfer
anoth
steril
plate
hemoglobin
releas
cell
determin
nm
addit
dmso
medium
affect
integr
erythrocyt
membran
hemolysi
assay
repeat
twice
best
conform
six
inhibitor
output
superimpos
use
disco
program
encod
multiconform
gener
flex
search
use
multisearch
reject
featur
reject
featur
remov
duplic
leav
set
uniqu
low
energi
conform
disco
produc
number
possibl
pharmacophor
hypothes
group
basi
assign
atom
featur
four
featur
contain
two
hydrogen
donor
two
hydrophob
center
detect
disco
sm
ad
hj
dq
conceiv
design
whole
project
jz
perform
model
yycg
protein
structurebas
virtual
screen
potenti
inhibitor
supervis
hj
zq
bx
lc
yw
xy
particip
biolog
experi
leadcompound
xs
sm
dq
supervis
experi
zq
jz
lc
yw
ad
analyz
data
produc
figur
zq
jz
sm
ad
hj
dq
draft
manuscript
author
read
approv
final
manuscript
